Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia

计划入组 167 人 · 首次发布于 2013 年 7 月 12 日

Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia

首次发布于 2020 年 10 月 22 日

Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia

计划入组 14 人 · 首次发布于 2013 年 11 月 5 日

anti-MRSA antibody

ZBIA-3H

MRSA vaccines (Abcombi Biosciences)

Mesa Air Group

MSA Safety

Egypt

QPS MRA, LLC

United States

LyticGen Files Patent for CRISPR-Engineered Bacteriophage VDX-10 Targeting MRSA

IV Iron Treatment Improves Survival in Anemic Patients with Acute Bacterial Infections, Large-Scale Study Shows

FDA Grants Breakthrough Therapy Designation to Armata's Phage Therapy AP-SA02 for Complicated S. aureus Bacteremia